Hyperuricemia: From the Evolution of Species to Cardiovascular Risk

Authors

  • Fulvio Floccari Centro di Riferimento Regionale per la Nefrologia e la Dialisi “M. Biagini”, ASL RM4 - Civitavecchia (RM)
  • Luca Di Lullo UOC Nefrologia e Dialisi, Ospedale Parodi Delfino, Colleferro (RM)
  • Rodolfo Rivera UOC Nefrologia e Dialisi, Ospedale San Gerardo, Monza
  • Alberto Santoboni UOC Nefrologia e Dialisi, Ospedale Parodi Delfino, Colleferro (RM)
  • Andrea Stella UOC Nefrologia e Dialisi, Ospedale San Gerardo, Monza
  • Moreno Malaguti Centro di Riferimento Regionale per la Nefrologia e la Dialisi “M. Biagini”, ASL RM4 - Civitavecchia (RM)

DOI:

https://doi.org/10.33393/gcnd.2016.736

Keywords:

Cardiorenal syndrome, Chronic renal failure, Gout, Uric acid

Abstract

In this review we analyze the cardiorenal effects of hyperuricemia and try to answer the eternal question of whether it is or is not to be considered a true risk factor in addition to a well-established marker of cardiovascular, cerebrovascular and renal risk. (Cardionephrology)

Downloads

Download data is not yet available.

Downloads

Published

2016-11-28

How to Cite

Floccari, F., Di Lullo, L., Rivera, R., Santoboni, A., Stella, A., & Malaguti, M. (2016). Hyperuricemia: From the Evolution of Species to Cardiovascular Risk. Giornale Di Clinica Nefrologica E Dialisi, 28(4), 278–281. https://doi.org/10.33393/gcnd.2016.736

Issue

Vol. 28 No. 4 (2016): October-December 2016

Section

Cardionephrology

License

Authors contributing to Giornale di Clinica Nefrologica e Dialisi (GCND) agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.

Metrics

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)

1 2 3 4 > >>